<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33712624</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>12</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43.</ArticleTitle><Pagination><StartPage>1620</StartPage><MedlinePgn>1620</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1620</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-21912-y</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis and several other neurodegenerative diseases are associated with brain deposits of amyloid-like aggregates formed by the C-terminal fragments of TDP-43 that contain the low complexity domain of the protein. Here, we report the cryo-EM structure of amyloid formed from the entire TDP-43 low complexity domain in vitro at pH 4. This structure reveals single protofilament fibrils containing a large (139-residue), tightly packed core. While the C-terminal part of this core region is largely planar and characterized by a small proportion of hydrophobic amino acids, the N-terminal region contains numerous hydrophobic residues and has a non-planar backbone conformation, resulting in rugged surfaces of fibril ends. The structural features found in these fibrils differ from those previously found for fibrils generated from short protein fragments. The present atomic model for TDP-43 LCD fibrils provides insight into potential structural perturbations caused by phosphorylation and disease-related mutations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiuye</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0001-7869-8814</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babinchak</LastName><ForeName>W Michael</ForeName><Initials>WM</Initials><Identifier Source="ORCID">0000-0002-8299-287X</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surewicz</LastName><ForeName>Witold K</ForeName><Initials>WK</Initials><Identifier Source="ORCID">0000-0001-7940-6027</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA. wks3@case.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF1 AG061797</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM094357</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 AG059350</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007250</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS103848</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020285" MajorTopicYN="N">Cryoelectron Microscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057927" MajorTopicYN="N">Hydrophobic and Hydrophilic Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33712624</ArticleId><ArticleId IdType="pmc">PMC7955110</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-21912-y</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-21912-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VMY, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 2012;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 2008;173:182&#x2013;194. doi: 10.2353/ajpath.2008.080003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.080003</ArticleId><ArticleId IdType="pmc">PMC2438296</ArticleId><ArticleId IdType="pubmed">18535185</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA. 2009;106:7607&#x2013;7612. doi: 10.1073/pnas.0900688106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Yokoshi M, Okada H, Kawahara Y. The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat. Commun. 2015;6:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">25630387</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 2009;284:20329&#x2013;20339. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak WM, et al. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain. J. Biol. Chem. 2019;294:6306&#x2013;6317. doi: 10.1074/jbc.RA118.007222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007222</ArticleId><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VMY. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: Protein misfolding diseases without amyloidosis. Arch. Neurol. 2007;64:1388&#x2013;1394. doi: 10.1001/archneur.64.10.1388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.10.1388</ArticleId><ArticleId IdType="pubmed">17923623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin WL, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 2008;116:205&#x2013;213. doi: 10.1007/s00401-008-0408-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0408-9</ArticleId><ArticleId IdType="pmc">PMC2706695</ArticleId><ArticleId IdType="pubmed">18607609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio EH, et al. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol. 2013;125:463&#x2013;465. doi: 10.1007/s00401-013-1089-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1089-6</ArticleId><ArticleId IdType="pmc">PMC3593646</ArticleId><ArticleId IdType="pubmed">23378033</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, et al. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125:121&#x2013;131. doi: 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N. A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 2011;286:18664&#x2013;18672. doi: 10.1074/jbc.M111.231209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.231209</ArticleId><ArticleId IdType="pmc">PMC3099683</ArticleId><ArticleId IdType="pubmed">21454603</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Sidle KCL, Hardy J. Prion-like mechanisms of transactive response DNA binding protein of 43kDa (TDP-43) in amyotrophic lateral sclerosis (ALS) Neuropathol. Appl. Neurobiol. 2015;41:578&#x2013;597. doi: 10.1111/nan.12206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12206</ArticleId><ArticleId IdType="pubmed">25487060</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima M, Tan R, Halliday GM, Kril JJ. Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol. Commun. 2015;3:47. doi: 10.1186/s40478-015-0226-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0226-y</ArticleId><ArticleId IdType="pmc">PMC4517552</ArticleId><ArticleId IdType="pubmed">26216351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuo XF, et al. Solid-state NMR reveals the structural transformation of the TDP-43 amyloidogenic region upon fibrillation. J. Am. Chem. Soc. 2020;142:3412&#x2013;3421. doi: 10.1021/jacs.9b10736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.9b10736</ArticleId><ArticleId IdType="pubmed">32003979</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy J, et al. Structural dissection of amyloid aggregates of TDP-43 and its C-terminal fragments TDP-35 and TDP-16. FEBS J. 2020;287:2449&#x2013;2467. doi: 10.1111/febs.15159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15159</ArticleId><ArticleId IdType="pubmed">31782904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Boyer DR, Sawaya MR, Ge P, Eisenberg DS. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. 2019;26:619&#x2013;627. doi: 10.1038/s41594-019-0248-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0248-4</ArticleId><ArticleId IdType="pmc">PMC7047951</ArticleId><ArticleId IdType="pubmed">31235914</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171:615.e16&#x2013;627.e16. doi: 10.1016/j.cell.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.08.048</ArticleId><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, M., Ghosh, U., Thurber, K. R., Kato, M. &amp; Tycko, R. Molecular structure and interactions within amyloid-like fibrils formed by a low-complexity protein sequence from FUS. Nat. Commun. 11, 5735 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665218</ArticleId><ArticleId IdType="pubmed">33184287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremer L, et al. Fibril structure of amyloid-&#x3b2;(1&#x2013;42) by cryo-electron microscopy. Science. 2017;358:116&#x2013;119. doi: 10.1126/science.aao2825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao2825</ArticleId><ArticleId IdType="pmc">PMC6080689</ArticleId><ArticleId IdType="pubmed">28882996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmer M, et al. Cryo-EM structure and polymorphism of A&#x3b2; amyloid fibrils purified from Alzheimer&#x2019;s brain tissue. Nat. Commun. 2019;10:1&#x2013;8. doi: 10.1038/s41467-019-12683-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12683-8</ArticleId><ArticleId IdType="pmc">PMC6820800</ArticleId><ArticleId IdType="pubmed">31664019</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature. 2018;561:137&#x2013;140. doi: 10.1038/s41586-018-0454-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0454-y</ArticleId><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, W. et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer&#x2019;s and Pick&#x2019;s diseases. Elife8, e43584 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375701</ArticleId><ArticleId IdType="pubmed">30720432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580:283&#x2013;287. doi: 10.1038/s41586-020-2043-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2043-0</ArticleId><ArticleId IdType="pmc">PMC7148158</ArticleId><ArticleId IdType="pubmed">32050258</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Ferreira, R. et al. Cryo-EM structure of alpha-synuclein fibrils. Elife7, e36402 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092118</ArticleId><ArticleId IdType="pubmed">29969391</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, B. et al. Cryo-EM of full-length &#x3b1;-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6127345</ArticleId><ArticleId IdType="pubmed">30190461</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer DR, et al. Structures of fibrils formed by &#x3b1;-synuclein hereditary disease mutant H50Q reveal new polymorphs. Nat. Struct. Mol. Biol. 2019;26:1044&#x2013;1052. doi: 10.1038/s41594-019-0322-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0322-y</ArticleId><ArticleId IdType="pmc">PMC6907165</ArticleId><ArticleId IdType="pubmed">31695184</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, et al. Structures of &#x3b1;-synuclein filaments from multiple system atrophy. Nature. 2020;585:464&#x2013;469. doi: 10.1038/s41586-020-2317-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2317-6</ArticleId><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadanza MG, et al. The structure of a &#x3b2;2-microglobulin fibril suggests a molecular basis for its amyloid polymorphism. Nat. Commun. 2018;9:4517. doi: 10.1038/s41467-018-06761-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06761-6</ArticleId><ArticleId IdType="pmc">PMC6207761</ArticleId><ArticleId IdType="pubmed">30375379</ArticleId></ArticleIdList></Reference><Reference><Citation>Radamaker, L. et al. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. Nat. Commun. 10, 1103 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6427026</ArticleId><ArticleId IdType="pubmed">30894526</ArticleId></ArticleIdList></Reference><Reference><Citation>Swuec, P. et al. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient. Nat. Commun. 10, 1269 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6427027</ArticleId><ArticleId IdType="pubmed">30894521</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, M. et al. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat. Commun. 10, 5008 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6825171</ArticleId><ArticleId IdType="pubmed">31676763</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;der, C. et al. Atomic structure of PI3-kinase SH3 amyloid fibrils by cryo-electron microscopy. Nat. Commun. 10, 3754 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6704188</ArticleId><ArticleId IdType="pubmed">31434882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LQ, et al. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat. Struct. Mol. Biol. 2020;27:598&#x2013;602. doi: 10.1038/s41594-020-0441-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0441-5</ArticleId><ArticleId IdType="pubmed">32514176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya, M. R. Amyloid atlas. https://people.mbi.ucla.edu/sawaya/amyloidatlas/ (2020).</Citation></Reference><Reference><Citation>Neumann M, et al. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD&#x2013;TDP subtypes. Acta Neuropathol. 2020;140:645&#x2013;658. doi: 10.1007/s00401-020-02207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02207-w</ArticleId><ArticleId IdType="pmc">PMC7547034</ArticleId><ArticleId IdType="pubmed">32778941</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom&#xe9; SO, et al. Distinct molecular patterns of TDP-43 pathology in Alzheimer&#x2019;s disease: relationship with clinical phenotypes. Acta Neuropathol. Commun. 2020;8:61. doi: 10.1186/s40478-020-00934-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00934-5</ArticleId><ArticleId IdType="pmc">PMC7189555</ArticleId><ArticleId IdType="pubmed">32349792</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Li K, Jiang W. Antibody-based affinity cryo-EM grid. Methods. 2016;100:16&#x2013;24. doi: 10.1016/j.ymeth.2016.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2016.01.010</ArticleId><ArticleId IdType="pmc">PMC4848123</ArticleId><ArticleId IdType="pubmed">26804563</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokori-Brown M, et al. Cryo-EM structure of lysenin pore elucidates membrane insertion by an aerolysin family protein. Nat. Commun. 2016;7:1&#x2013;7. doi: 10.1038/ncomms11293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11293</ArticleId><ArticleId IdType="pmc">PMC4823867</ArticleId><ArticleId IdType="pubmed">27048994</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronarde DN. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 2005;152:36&#x2013;51. doi: 10.1016/j.jsb.2005.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2005.07.007</ArticleId><ArticleId IdType="pubmed">16182563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331&#x2013;332. doi: 10.1038/nmeth.4193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 2016;193:1&#x2013;12. doi: 10.1016/j.jsb.2015.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.11.003</ArticleId><ArticleId IdType="pmc">PMC4711343</ArticleId><ArticleId IdType="pubmed">26592709</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 2012;180:519&#x2013;530. doi: 10.1016/j.jsb.2012.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC3690530</ArticleId><ArticleId IdType="pubmed">23000701</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Scheres SHW. Helical reconstruction in RELION. J. Struct. Biol. 2017;198:163&#x2013;176. doi: 10.1016/j.jsb.2017.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2017.02.003</ArticleId><ArticleId IdType="pmc">PMC5479445</ArticleId><ArticleId IdType="pubmed">28193500</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ. 2019;6:5&#x2013;17. doi: 10.1107/S205225251801463X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S205225251801463X</ArticleId><ArticleId IdType="pmc">PMC6327179</ArticleId><ArticleId IdType="pubmed">30713699</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ. 2020;7:253&#x2013;267. doi: 10.1107/S2052252520000081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2052252520000081</ArticleId><ArticleId IdType="pmc">PMC7055373</ArticleId><ArticleId IdType="pubmed">32148853</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2010;66:486&#x2013;501. doi: 10.1107/S0907444910007493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 2010;66:213&#x2013;221. doi: 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605&#x2013;1612. doi: 10.1002/jcc.20084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Word JM, Lovell SC, Richardson JS, Richardson DC. Asparagine and glutamine: Using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 1999;285:1735&#x2013;1747. doi: 10.1006/jmbi.1998.2401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1998.2401</ArticleId><ArticleId IdType="pubmed">9917408</ArticleId></ArticleIdList></Reference><Reference><Citation>Word JM, et al. Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms. J. Mol. Biol. 1999;285:1711&#x2013;1733. doi: 10.1006/jmbi.1998.2400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1998.2400</ArticleId><ArticleId IdType="pubmed">9917407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982;157:105&#x2013;132. doi: 10.1016/0022-2836(82)90515-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(82)90515-0</ArticleId><ArticleId IdType="pubmed">7108955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>